Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial

OBJECTIVE: The aim of this study was to examine the clinical efficacy and safety of the duodenal-jejunal bypass liner (DJBL) while in situ for 12 months and for 12 months after explantation. SUMMARY BACKGROUND DATA: This is the largest randomized controlled trial (RCT) of the DJBL, a medical device...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruban, Aruchuna, Miras, Alexander D., Glaysher, Michael A., Goldstone, Anthony P., Prechtl, Christina G., Johnson, Nicholas, Chhina, Navpreet, Al-Najim, Werd, Aldhwayan, Madhawi, Klimowska-Nassar, Natalia, Smith, Claire, Lord, Joanne, Li, Jia V., Flores, Lilliam, Al-Lababidi, Moaz, Dimitriadis, Georgios K., Patel, Mayank, Moore, Michael, Chahal, Harvinder, Ahmed, Ahmed R., Cousins, Jonathan, Aldubaikhi, Ghadah, Glover, Ben, Falaschetti, Emanuela, Ashrafian, Hutan, le Roux, Carel W., Darzi, Ara, Byrne, James P., Teare, Julian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Randomized Controlled Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820769/
https://www.ncbi.nlm.nih.gov/pubmed/34647708
http://dx.doi.org/10.1097/SLA.0000000000004980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820769/
https://www.ncbi.nlm.nih.gov/pubmed/34647708
http://dx.doi.org/10.1097/SLA.0000000000004980

Ejemplares similares